EE200600039A - Transgeenne loommudel patoloogilise ärevuse modelleerimiseks, meetod patoloogilisest ärevusest p?hjustatud haiguste v?i seisundite ravimiseks sobilike ühendite tuvastamiseks ja meetod Wfs1 valgu kasutamiseks sihtmärgina patoloogilise ärevuse vastase - Google Patents
Transgeenne loommudel patoloogilise ärevuse modelleerimiseks, meetod patoloogilisest ärevusest p?hjustatud haiguste v?i seisundite ravimiseks sobilike ühendite tuvastamiseks ja meetod Wfs1 valgu kasutamiseks sihtmärgina patoloogilise ärevuse vastaseInfo
- Publication number
- EE200600039A EE200600039A EEP200600039A EEP200600039A EE200600039A EE 200600039 A EE200600039 A EE 200600039A EE P200600039 A EEP200600039 A EE P200600039A EE P200600039 A EEP200600039 A EE P200600039A EE 200600039 A EE200600039 A EE 200600039A
- Authority
- EE
- Estonia
- Prior art keywords
- pathological anxiety
- anxiety
- pathological
- treatment
- conditions
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title 3
- 230000001575 pathological effect Effects 0.000 title 3
- 230000036506 anxiety Effects 0.000 title 2
- 238000000034 method Methods 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 230000018883 protein targeting Effects 0.000 title 1
- 238000012301 transgenic model Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Cell Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EEP200600039A EE200600039A (et) | 2006-12-12 | 2006-12-12 | Transgeenne loommudel patoloogilise ärevuse modelleerimiseks, meetod patoloogilisest ärevusest p?hjustatud haiguste v?i seisundite ravimiseks sobilike ühendite tuvastamiseks ja meetod Wfs1 valgu kasutamiseks sihtmärgina patoloogilise ärevuse vastase |
| US12/518,422 US20100146645A1 (en) | 2006-12-12 | 2007-12-10 | Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfs1 protein as a target for identifying effective compounds against pathological anxiety |
| EP07846471A EP2176290A1 (en) | 2006-12-12 | 2007-12-10 | Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety |
| PCT/EE2007/000025 WO2008071201A1 (en) | 2006-12-12 | 2007-12-10 | Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EEP200600039A EE200600039A (et) | 2006-12-12 | 2006-12-12 | Transgeenne loommudel patoloogilise ärevuse modelleerimiseks, meetod patoloogilisest ärevusest p?hjustatud haiguste v?i seisundite ravimiseks sobilike ühendite tuvastamiseks ja meetod Wfs1 valgu kasutamiseks sihtmärgina patoloogilise ärevuse vastase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200600039A true EE200600039A (et) | 2008-10-15 |
Family
ID=39168095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200600039A EE200600039A (et) | 2006-12-12 | 2006-12-12 | Transgeenne loommudel patoloogilise ärevuse modelleerimiseks, meetod patoloogilisest ärevusest p?hjustatud haiguste v?i seisundite ravimiseks sobilike ühendite tuvastamiseks ja meetod Wfs1 valgu kasutamiseks sihtmärgina patoloogilise ärevuse vastase |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100146645A1 (et) |
| EP (1) | EP2176290A1 (et) |
| EE (1) | EE200600039A (et) |
| WO (1) | WO2008071201A1 (et) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9238150B2 (en) | 2005-07-22 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Optical tissue interface method and apparatus for stimulating cells |
| US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
| US8906360B2 (en) | 2005-07-22 | 2014-12-09 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated cation channel and uses thereof |
| US8926959B2 (en) | 2005-07-22 | 2015-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| US10052497B2 (en) | 2005-07-22 | 2018-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| WO2008086470A1 (en) | 2007-01-10 | 2008-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| WO2008101128A1 (en) | 2007-02-14 | 2008-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
| WO2008106694A2 (en) | 2007-03-01 | 2008-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Systems, methods and compositions for optical stimulation of target cells |
| US10434327B2 (en) | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
| US10035027B2 (en) | 2007-10-31 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for ultrasonic neuromodulation via stereotactic frame based technique |
| MY169771A (en) | 2008-04-23 | 2019-05-15 | Univ Leland Stanford Junior | Systems, methods and compositions for optical stimulation of target cells |
| AU2009256457B2 (en) | 2008-05-29 | 2014-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Cell line, system and method for optical control of secondary messengers |
| CA2728238C (en) | 2008-06-17 | 2019-03-12 | M. Bret Schneider | Methods, systems and devices for optical stimulation of target cells using an optical transmission element |
| BRPI0915583A2 (pt) | 2008-06-17 | 2016-01-26 | Univ Leland Stanford Junior | aparelho e métodos para controle do desenvolvimento celular |
| US9101759B2 (en) | 2008-07-08 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
| NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
| CA2791094A1 (en) | 2010-03-17 | 2011-09-22 | The Board Of Trustees Of The Leland Stanford Junior University | Light-sensitive ion-passing molecules |
| EP3225108A1 (en) | 2010-11-05 | 2017-10-04 | The Board of Trustees of The Leland Stanford Junior University | Optogenetic control of reward-related behaviors |
| CN103491770B (zh) | 2010-11-05 | 2016-06-08 | 斯坦福大学托管董事会 | 稳定阶跃函数视蛋白及其使用方法 |
| EP2635341B1 (en) | 2010-11-05 | 2018-08-08 | The Board of Trustees of the Leland Stanford Junior University | Upconversion of light for use in optogenetic methods |
| CA2816971A1 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated chimeric opsins and methods of using the same |
| WO2012061690A2 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Optically-controlled cns dysfunction |
| CN106376525A (zh) | 2010-11-05 | 2017-02-08 | 斯坦福大学托管董事会 | 记忆功能的控制和表征 |
| US8696722B2 (en) | 2010-11-22 | 2014-04-15 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic magnetic resonance imaging |
| EP3524676A1 (en) | 2011-12-16 | 2019-08-14 | The Board of Trustees of The Leland Stanford Junior University | Opsin polypeptides and methods of use thereof |
| EP2817068B1 (en) | 2012-02-21 | 2017-04-12 | The Board of Trustees of the Leland Stanford Junior University | Compositions for treating neurogenic disorders of the pelvic floor |
| CA2906756A1 (en) * | 2013-03-15 | 2014-09-18 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of behavioral state |
| US9636380B2 (en) | 2013-03-15 | 2017-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of inputs to the ventral tegmental area |
| JP6549559B2 (ja) | 2013-04-29 | 2019-07-24 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 標的細胞における活動電位の光遺伝学的調節のための装置、システム及び方法 |
| CN105829538A (zh) | 2013-08-14 | 2016-08-03 | 小利兰·斯坦福大学托管委员会 | 用于控制疼痛的组合物和方法 |
| WO2016209654A1 (en) | 2015-06-22 | 2016-12-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for imaging and/or optogenetic control of light-responsive neurons |
| US11294165B2 (en) | 2017-03-30 | 2022-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modular, electro-optical device for increasing the imaging field of view using time-sequential capture |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6060642A (en) * | 1997-08-15 | 2000-05-09 | The Regents Of The University Of California | Serotonin 5-HT6 receptor knockout mouse |
| CA2375943A1 (en) * | 1999-07-15 | 2001-01-25 | Research Development Foundation | Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| EP1353549A2 (en) * | 2000-06-01 | 2003-10-22 | PHARMACIA & UPJOHN COMPANY | Mice heterozygous for wfs1 gene as mouse models for depression |
| US7037695B2 (en) * | 2001-02-02 | 2006-05-02 | Pharmacia & Upjohn | Methods of assessing wolframin protein activity |
| US20040058405A1 (en) * | 2002-01-30 | 2004-03-25 | Hiebsch Ronald R. | Methods of assessing wolframin protein activity |
-
2006
- 2006-12-12 EE EEP200600039A patent/EE200600039A/et unknown
-
2007
- 2007-12-10 EP EP07846471A patent/EP2176290A1/en not_active Withdrawn
- 2007-12-10 US US12/518,422 patent/US20100146645A1/en not_active Abandoned
- 2007-12-10 WO PCT/EE2007/000025 patent/WO2008071201A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2176290A1 (en) | 2010-04-21 |
| WO2008071201A1 (en) | 2008-06-19 |
| US20100146645A1 (en) | 2010-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021009I2 (el) | Αντισωματα αντι-ρ-σελεκτινης και μεθοδοι χρησης αυτων στην αντιμετωπιση φλεγμονωδων νοσων | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| DE602007004092D1 (de) | C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| DE502005007427D1 (de) | 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten | |
| EP2207595A4 (en) | SYSTEM AND METHOD FOR PACKAGING LASER RAY ANIMAL TISSUE | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| EP1896083A4 (en) | METHOD FOR TREATING PUMP DISEASE USING 1-DEOXYNOJIRIMYCIN AND ITS DERIVATIVES | |
| DK1706112T3 (da) | Fremgangsmåder til at behandle en inflammatorisk-beslægtet sygdom | |
| ATE542823T1 (de) | 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| HRP20150449T1 (xx) | Metode lijeäśenja multiplog mijeloma primjenom kombiniranih terapija temeljenih na anti-cs1 antitijelima | |
| DK2200616T3 (da) | Mipo-hæmmere til behandling huntingtons sygdom og multipel system atrofi | |
| DK1993589T3 (da) | Behandlinger for neurologiske sygdomme | |
| IL192790A0 (en) | Method and markers for the diagnosis of renal diseases | |
| EP2236150A4 (en) | METHOD FOR INCREASING THE THERAPEUTIC EFFECTIVENESS OF CURCUMINOIDS AND ANALOGUE | |
| DK1817282T3 (da) | Til behandling af respiratoriske sygdomme egnede phenoxy derivater | |
| ATE447551T1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| EP3769718C0 (en) | DEVICE FOR TREATING AN INTESTINAL DISORDER | |
| EP1862081A4 (en) | FEED COMPOSITION AND METHOD FOR BREEDING ANIMALS | |
| ITRM20040212A1 (it) | Animale transgenico non umano come modello per malattie neurodegenerative e per la loro diagnosi precoce. | |
| FI20041483L (fi) | Järjestelmä ja menetelmä alkion toimittamiseksi valmistettuja siemeniä varten | |
| ATE525355T1 (de) | 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1 | |
| PL2279264T3 (pl) | Sposób charakteryzowania aktywności biologicznej jaj nicieni z rodzaju trichuris |